Here is the latest News Briefing from PARITY:

News Items:

Equality statistics
New Domestic Violence and Abuse Act
Britain¡¦s boy crisis
CPS feminisation
Gender pay gap
The Justice Gender Gap
Prostate cancer

Equality statistics

The way that so-called ‘equality’ statistics are manipulated to disfavour males, was well illustrated by a letter from a Dr Steven Field published in the Daily Telegraph in October 2016.

‘Being equal in Britain’.

Sir, Those shocked by Britain’s place in the Global Gender Equality Index (report, October 26), which puts us 26th – below countries such as Rwanda – may like to consider the way in which the index is calculated.

In its statement on methodology the Index admits that it ignores any cases where women “out-perform” men. In top-of-the-table-Iceland, for example, only 37 per cent of students in tertiary education are male, but this does not count as a gender gap. If it were the other way round, it would count as a huge gap.

The Index also assumes that women are entitled to have healthy lives at least 6 per cent longer than those of men. In the UK, the difference in life expectancy is only 4 per cent, and this therefore counts as a gender gap disadvantaging women.

Some inequalities, such as male-only compulsory military service or an earlier pension age for women, are ignored completely. The Index may serve a purpose in that it indicates areas where women are disadvantaged, but it is certainly not an even-handed measure of equality.

Prostate Cancer

Every year thousands of men are diagnosed with advanced prostate cancer. It is hoped that with more targeted research, some progress will be made to allow men to hope that eventually a cure will be found for this.

The charity Prostate Cancer Research UK has announced recently that as part of such new research, it is proceeding with a new trial – ADRRAD, in an attempt to help find such a cure. ‘It’s the first of its kind and could potentially change the way we treat, diagnose and prevent prostate cancer’.

The theory is simple – by combining current effective cancer treatments with a drug called radium-223, the hope is that it can ‘stop advanced prostate cancer in its tracks’.

Prostate Cancer UK claims that the potential of this work is huge. But they need more funding support to afford the equipment and staff they need to run this ground-breaking trial.

Any gifts or donations would be welcome to support this work. Prostate Cancer UK can be contacted on 020 3310 7000. Details can be found on the Prostate Cancer website.

PARITY March 2017.

View Full Article Here.